Suppr超能文献

结直肠癌合并梗阻的治疗结果

Results of the treatment of colorectal cancer complicated by obstruction.

作者信息

Stoyanov H, Julianov A, Valtchev D, Matev A

机构信息

Department of General Surgery, Thracian University, Stara Zagora, Bulgaria.

出版信息

Wien Klin Wochenschr. 1998 Apr 10;110(7):262-5.

PMID:9611342
Abstract

654 patients with colorectal cancer were operated on during the period 1982-1993. Acute surgical intervention was performed in 232 cases because of large bowel obstruction, whereby the obstruction tumor was localized in the colon in 160 patients and in the rectum in the remaining 72 patients. 53 of the patients were designated as stage T3,4N-M0 stage, 97 as T3,4N+M0 and 82 as T3,4N+/-M1. Histologically, well- and moderately-differentiated adenocarcinoma was diagnosed in 69%, poorly differentiated and mucinous adenocarcinoma in 29% and squamous cancer in 2% of the cases. The patients were distributed in 4 groups according to the clinical presentation of the obstruction: acute (n = 60), subacute (n = 52), recurring (n = 42) and chronic (n = 78) forms. 122 radical and 110 palliative operations were performed. 34% of the patients had postoperative complications. The overall postoperative mortality was 25% AND it was highest in one-stage operation with a primary anastomosis (p < 0.05). The 5-year survival in patients with obstructive colon and rectal tumours was 32% and 27%, respectively (p = 0.631). The patients with differentiated adenocarcinoma have a better prognosis, as well as those without regional lymph node metastases (p < 0.05). The patients without obstruction operated on during the same period, had a higher 5-year survival for both colon (p < 0.01) and rectal (p < 0.0019) cancer.

摘要

1982年至1993年期间,654例结直肠癌患者接受了手术治疗。232例因大肠梗阻进行了急性手术干预,其中梗阻性肿瘤位于结肠的有160例,位于直肠的有其余72例。53例患者被定为T3、4N-M0期,97例为T3、4N+M0期,82例为T3、4N+/-M1期。组织学检查显示,69%的病例诊断为高分化和中分化腺癌,29%为低分化和黏液腺癌,2%为鳞癌。根据梗阻的临床表现,患者分为4组:急性(n = 60)、亚急性(n = 52)、复发性(n = 42)和慢性(n = 78)。进行了122例根治性手术和110例姑息性手术。34%的患者有术后并发症。总体术后死亡率为25%,一期吻合的一期手术中死亡率最高(p < 0.05)。梗阻性结肠癌和直肠癌患者的5年生存率分别为32%和27%(p = 0.631)。高分化腺癌患者以及无区域淋巴结转移的患者预后较好(p < 0.05)。同期接受手术的无梗阻患者,结肠癌(p < 0.01)和直肠癌(p < 0.0019)的5年生存率更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验